Ozempic and Wegovy for Weight Loss: A Metabolic Miracle or a Medical Minefield for Non-Diabetics?
The quest for effective weight management has long been a complex, often frustrating, journey for millions. As we navigate early 2026, the health landscape is dominated by a pharmaceutical revolution: the rise of GLP-1 receptor agonists (GLP-1 RAs). Medications like semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (Mounjaro) have burst from the confines of …